News & Events
As our company evolves we may from time to time post updates and news.
News & Events
04-02-2026
EU HTA Regulation: Early Signals, Open Questions, and Practical Choices for Biotechs
In our fifth and final webinar on the new EU HTA Regulation, Chantal van Gils and Mel Walker will reflect on how the regulation is beginning to play out in practice for small and mid-size biotech teams preparing for EU market access.
18-12-2025
SSI Strategy Partners with Ready Room to Strengthen Inspection Readiness for Biotech Leaders
SSI has partnered with Ready Room, a purpose-built platform that helps teams manage & streamline inspection readiness activities across the product lifecycle.
29-09-2025
SSI Strategy to Join Clinigen Group, Charting a Seamless Path from Clinical Strategy to Global Commercialisation
Clinigen to Acquire SSI Strategy, Charting a Seamless Path from Clinical Strategy to Global Commercialisation for Biotech Innovators
18-09-2025
SSI Strategy Achieves Top 5 Ranking in Consulting Magazine’s Best Firms to Work For
We are delighted to announce that SSI Strategy has been ranked #5 in Consulting Magazine's Best Small Firms to Work For 2025.
09-05-2025
EU HTA Regulation: Joint Scientific Consultation – Key Steps, Timing & Strategy
Join our experts Chantal W.M. van Gils & Sigrid Klaar on Thursday, 5th June at 14:00 BST | 15:00 CEST | 09:00 EDT for the fourth installment of our webinar series on the European Health Technology Assessment (HTA) regulation.
21-01-2025
EU HTA Regulation: JCA in Practice – From Procedure to Evidence Generation
Join our experts Chantal W.M. van Gils & Sigrid Klaar on Thursday, 23rd January at 14:00 UK | 15:00 CET | 09:00 EST for the third installment of our webinar series on the European Health Technology Assessment (HTA) regulation.
LET'S TALK
You don't have to go it alone!
Our experienced team has been there before, and we're ready to guide you through the unknown.Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs
